Dr. Marcel E. Zughaib, MD

Dr. Zughaib practices at St John Hospital and Medical Center - Assarian Cancer Center - HOPD in Novi, Michigan.

Dr. Zughaib's NPI, 1922038488, was assigned on July 3, 2006. Dr. Zughaib holds Michigan license 062985.

Dr. Zughaib's primary practice is St John Hospital and Medical Center - Assarian Cancer Center - HOPD, at 47601 Grand River Ave, Novi, MI 48374.

Dr. Zughaib's primary practice is St John Hospital and Medical Center - Assarian Cancer Center - HOPD in Novi, Michigan. Dr. Zughaib is also affiliated with University Hospital. The medical group on file is Henry Ford Health Providence Hospital. Dmand AI also links Dr. Zughaib to 4 more hospitals, 3 group practices and clinics, 2 medical groups and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zughaib practices, 10 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Zughaib's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Zughaib is licensed in Michigan.

CMS data shows 2,572 Medicare services from Dr. Zughaib across 15 procedure codes in 2024, for 746 Medicare patients. Medicare paid $105,211 for them.

CMS counts 746 Medicare patients who saw Dr. Zughaib in 2024. The largest group is 65 to 74, with 308 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zughaib's median patient age at 73, with 45% women.

In 2024, Dr. Zughaib wrote 7,599 Medicare Part D claims for 897 patients. 90% of them were for generic drugs. CMS names the drug for 7,415 of them, across 50 drugs with 11 or more claims each, at $1,006,265 in total drug cost. In 2023, CMS named 7,122 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Zughaib for performance year 2024, reported through an alternative payment model (APM). Dr. Zughaib accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of coronary angioplasty and stenting by Dr. Zughaib, more than 35% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 52 papers to Dr. Zughaib, published from 2014 to 2024. 2018 was the busiest year, with 9. The most frequent topics are Hemodynamics, Coronary Angiography and Diagnosis, Differential. Dr. Zughaib has published most often in Cureus. Dr. Zughaib's most frequent co-authors are Marc Thomas Zughaib, DO, Robby Ranbir Singh, MD and Andrew Davis Assaf, MD.

Dmand AI links Dr. Zughaib to 1 clinical trial. Conditions studied include Heart Failure, Diastolic and Heart Failure, Systolic.

CMS Open Payments shows 1,161 general payments to Dr. Zughaib from 62 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Janssen Pharmaceuticals, Inc paid the most, $238,357.